DK0773780T3 - Vandig controlled released-emulsion - Google Patents

Vandig controlled released-emulsion

Info

Publication number
DK0773780T3
DK0773780T3 DK95924647T DK95924647T DK0773780T3 DK 0773780 T3 DK0773780 T3 DK 0773780T3 DK 95924647 T DK95924647 T DK 95924647T DK 95924647 T DK95924647 T DK 95924647T DK 0773780 T3 DK0773780 T3 DK 0773780T3
Authority
DK
Denmark
Prior art keywords
oil
weight percent
total composition
value
emulsion
Prior art date
Application number
DK95924647T
Other languages
Danish (da)
English (en)
Inventor
S Esmail Tabibi
Robert W Mendes
Nitin P Pathak
Original Assignee
Ascent Pediatrics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascent Pediatrics Inc filed Critical Ascent Pediatrics Inc
Application granted granted Critical
Publication of DK0773780T3 publication Critical patent/DK0773780T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Colloid Chemistry (AREA)
DK95924647T 1994-06-21 1995-06-21 Vandig controlled released-emulsion DK0773780T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26327794A 1994-06-21 1994-06-21
US08/491,626 US5672358A (en) 1994-06-21 1995-06-19 Controlled release aqueous emulsion
PCT/US1995/007908 WO1995035096A1 (en) 1994-06-21 1995-06-21 Controlled release aqueous emulsion

Publications (1)

Publication Number Publication Date
DK0773780T3 true DK0773780T3 (da) 2002-09-09

Family

ID=26949751

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95924647T DK0773780T3 (da) 1994-06-21 1995-06-21 Vandig controlled released-emulsion

Country Status (11)

Country Link
US (1) US5672358A (de)
EP (1) EP0773780B1 (de)
JP (1) JP3583435B2 (de)
AT (1) ATE217186T1 (de)
AU (1) AU706516B2 (de)
CA (1) CA2193497C (de)
DE (1) DE69526655T2 (de)
DK (1) DK0773780T3 (de)
ES (1) ES2176333T3 (de)
WO (1) WO1995035096A1 (de)
ZA (1) ZA955153B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703319B1 (en) 1999-06-17 2004-03-09 Micron Technology, Inc. Compositions and methods for removing etch residue

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751222B1 (fr) * 1996-07-16 1998-10-09 Capsulis Compositions contenant au moins un acide nucleique et leurs applications dans le domaine biomedical, en particulier en therapie genique
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US7541020B2 (en) * 1997-05-08 2009-06-02 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
EP1189597A4 (de) * 1999-06-04 2008-06-18 Pacira Pharmaceuticals Inc Zusammensetzungen mit einem öl-kern zur verzögerten freisetzung hydrophober arzneistoffe
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
JP2004519504A (ja) * 2001-03-27 2004-07-02 アール．ピー． シェーラー テクノロジーズ インコーポレイテッド 製薬活性剤の改良形態およびその製造方法
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US7763663B2 (en) * 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
US20030139582A1 (en) * 2002-01-17 2003-07-24 Wang Kai Hua Composition containing biologically active polypeptides suitable for the oral administration
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
US20040213837A1 (en) * 2002-08-05 2004-10-28 Sankaram Mantripragada Oil-core compositions for the sustained release of hydrophobic drugs
AU2003302226A1 (en) * 2002-09-24 2004-06-30 University Of Kentucky Research Foundation Nanoparticle-based vaccine delivery system containing adjuvant
CA2430541A1 (en) * 2003-05-30 2004-11-30 Isomers Laboratories Cosmetic
DK1680097T3 (da) * 2003-10-27 2009-07-06 Dow Corning Præparater til topisk påföring og fremgangsmåder til afgivelse af et aktivt middel til et substrat
US8318210B2 (en) 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
CA2599676A1 (en) * 2005-03-04 2006-09-08 Dsm Ip Assets B.V. Foodstuff particulate lipid composition
WO2008010788A2 (en) 2005-07-18 2008-01-24 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
CA2620299A1 (en) * 2005-09-16 2007-03-22 Dsm Ip Assets B.V. Particulate lipid pharmaceutical composition
DK3144013T3 (en) 2005-12-01 2019-03-04 Univ Massachusetts Lowell Botulinum nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
CA2649109A1 (en) * 2006-04-12 2007-10-25 Biodel, Inc. Rapid acting and long acting insulin combination formulations
US20080118570A1 (en) * 2006-11-20 2008-05-22 Zhi Liu Polymer coated drug-ion exchange resins and methods
US20100150994A1 (en) 2006-12-01 2010-06-17 Anterios, Inc. Amphiphilic entity nanoparticles
JP5292304B2 (ja) 2006-12-01 2013-09-18 アンテリオス， インコーポレイテッド ペプチドナノ粒子およびその使用
KR20100050443A (ko) 2007-05-31 2010-05-13 안테리오스, 인코퍼레이티드 핵산 나노입자 및 이의 용도
GB201006215D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
US20120015913A1 (en) * 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
NZ608210A (en) * 2010-08-20 2015-02-27 Reddy’S Lab Ltd Dr Phospholipid depot
JP6121796B2 (ja) * 2012-05-23 2017-04-26 キユーピー株式会社 脂肪乳剤および医薬品組成物中の非ステロイド性抗炎症薬の含有量を高める方法
KR102487144B1 (ko) 2016-11-21 2023-01-12 에이리온 테라퓨틱스, 인코포레이티드 큰 물질의 경피 전달
CA3120453A1 (en) 2018-12-10 2020-06-18 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication
US11471475B1 (en) 2022-03-08 2022-10-18 Ralph P. Stone Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery
US11679078B1 (en) 2022-03-08 2023-06-20 EternaTear, Inc. Ophthalmic formulations and related methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
ES2136620T3 (es) * 1991-04-19 1999-12-01 Lds Technologies Inc Formulaciones de microemulsiones convertibles.
WO1993002665A1 (en) * 1991-07-26 1993-02-18 Smithkline Beecham Corporation W/o microemulsions
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703319B1 (en) 1999-06-17 2004-03-09 Micron Technology, Inc. Compositions and methods for removing etch residue

Also Published As

Publication number Publication date
JP3583435B2 (ja) 2004-11-04
WO1995035096A1 (en) 1995-12-28
DE69526655T2 (de) 2002-12-05
AU2907095A (en) 1996-01-15
US5672358A (en) 1997-09-30
CA2193497A1 (en) 1995-12-28
EP0773780A1 (de) 1997-05-21
JP2002510279A (ja) 2002-04-02
EP0773780B1 (de) 2002-05-08
CA2193497C (en) 2000-10-17
AU706516B2 (en) 1999-06-17
ZA955153B (en) 1996-05-07
ES2176333T3 (es) 2002-12-01
EP0773780A4 (de) 1998-09-30
DE69526655D1 (de) 2002-06-13
ATE217186T1 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
DK0773780T3 (da) Vandig controlled released-emulsion
CA2142103A1 (en) Submicron emulsions as ocular drug delivery vehicles
KR920017642A (ko) 고체 지질 입자의 현탁액을 함유한 국소제제
GR3022886T3 (en) Analgesic compositions
FR2767064B1 (fr) Procede de liberation d'un principe actif contenu dans une emulsion multiple
EP0272374A3 (de) Bioaktive Zusammensetzungen und Verfahren zu deren Herstellung und Verwendung
AU645108B2 (en) Prolonged release microcapsules
WO1999056727A3 (en) Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
IS4224A (is) Lyfjablanda á formi dropalausnar sem inniheldur skammvirkt kalsíummótlyf af tvíhýdrópýridíngerð semvinna gegn háþrýstingi
KR20180121251A (ko) 다층상 화장료 조성물
EP0626850A4 (de) Trockene zusammensetzung zur herstellung von emulsionen im submikron-bereich.
KR930001929A (ko) 안과용 조성물
AU2968089A (en) Emulsion compositions including amphipathic emulsifying agents
CZ59995A3 (en) Antivirally active pharmaceutical oil-in water emulsion containing 9/(2-hydroxyethoxy)methyl/quanine (acyclovirus) or salts or esters thereof
JPH08208508A (ja) 皮膚の赤みの治療におけるサブスタンスｐアンタゴニストの使用
RU2005100961A (ru) Композиция эмульсий для антиперспирантов
WO2001007058A3 (en) Parenteral cisplatin emulsion
WO1996032923A3 (de) Antitranspirantien
JPH0987130A (ja) 乳化組成物
ES2059827T3 (es) Emulsion para administracion parenteral.
DE60012068D1 (de) Zusammensetzung mit kontinuierlicher wässeriger Phase, die L-2-Oxothiazolidin- 4-carbonsäure enthält".
JP2001151635A (ja) 水中油型乳化皮膚外用剤
JPH07277988A (ja) 局所用掻痒除去、治療剤
US5607622A (en) Oil-in-water cream base
US5700789A (en) Antiallergic composition comprising a phosphoric diester compound